OnKure Therapeutics, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-13. Between them they name 1 person. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
The repricing generally applied to all outstanding and unexercised stock options to purchase shares of the Company's Class A common stock ("Shares") granted prior to January 1, 2025, under the Company's 2024 Equity Incentive Plan or the Company's 2021 Stock Incentive Plan (each, a "Plan"), with an exercise price per Share equal to or greater than $10.00, held by certain employees and consultants (such options, the "Eligible Options"), including each of the Company's named executive officers, as of the Effective Date.
Appointed: Liam Ratcliffe, Director
On March 27, 2026, in connection with the Private Placement, the Board elected Dr. Liam Ratcliffe as a Class I director of the Company, effective and contingent on the closing of the Private Placement.
Find people with the same kind of experience as the Director at OnKure Therapeutics, Inc., with the record behind each one.
Find candidates like Director at OnKure Therapeutics, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time OnKure Therapeutics, Inc. is in the news or changes leadership.
Get an alert when OnKure Therapeutics, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for OnKure Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.